Chikungunya virus disease
ICD-10 A92.0 is a billable code used to indicate a diagnosis of chikungunya virus disease.
Chikungunya virus disease is an arthropod-borne viral infection caused by the chikungunya virus, primarily transmitted to humans through the bite of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus. The disease is characterized by an abrupt onset of fever, severe joint pain, muscle pain, headache, nausea, fatigue, and rash. The joint pain can be debilitating and may persist for weeks to months, leading to significant morbidity. In some cases, the disease can lead to complications such as hemorrhagic manifestations, although this is rare. Travel history is crucial in diagnosing chikungunya, as outbreaks are common in tropical and subtropical regions, including parts of Africa, Asia, and the Americas. Clinicians should consider recent travel to endemic areas when evaluating patients with compatible symptoms. Laboratory confirmation can be achieved through serological tests or PCR, which can help differentiate chikungunya from other similar viral infections such as dengue fever. Proper coding and documentation are essential for accurate billing and to ensure appropriate patient management.
Detailed travel history, symptom onset, and laboratory results.
Patients presenting with fever and joint pain after travel to endemic areas.
Consideration of co-infections with other arboviruses.
Comprehensive patient history including travel and symptomatology.
Patients with flu-like symptoms returning from tropical regions.
Awareness of local outbreaks and patient education on prevention.
Used when serological confirmation of chikungunya is needed.
Document the reason for testing and patient symptoms.
Infectious disease specialists may order this test more frequently.
Common symptoms include fever, severe joint pain, muscle pain, headache, nausea, fatigue, and rash. Joint pain can be debilitating and may last for weeks to months.
Diagnosis is primarily clinical, supported by travel history and laboratory tests such as serology or PCR to confirm the presence of the chikungunya virus.
